Meta 10C-IL-10 TCR-T

N/A

Report date: 2023/03/07 16:43:58

Base Information

Drug NameMeta 10C-IL-10 TCR-T
Drug Alias NameMeta 10C-IL-10 TCR-T
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionInterleukin 10 receptor agonists
TargetsInterleukin 10 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLeman Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLeman Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A